scispace - formally typeset
S

Sijin Wu

Researcher at Ohio State University

Publications -  34
Citations -  722

Sijin Wu is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 11, co-authored 27 publications receiving 468 citations. Previous affiliations of Sijin Wu include Sun Yat-sen University & Dalian University of Technology.

Papers
More filters
Journal ArticleDOI

Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism *

TL;DR: This study demonstrates that Hc-CATH, the first cathelicidin from sea snake discovered to have both antimicrobial and anti-inflammatory activity, is a potent candidate for the development of peptide antibiotics.
Journal ArticleDOI

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.

TL;DR: A novel effect of flubendazole is demonstrated on suppressing breast CS-like cells and enhanced cytotoxic activity of conventional therapeutic drugs fluorouracil and doxorubicin against breast cancer cells.
Journal ArticleDOI

CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice.

TL;DR: It is shown that CRM1, an important nuclear exportin, is a cellular target of curcumin by serious experimental and theoretical investigation, and computational modeling has revealed thatCurcumin could be correctly docked into the hydrophobic pocket ofCRM1 judged from shape complementarity and putative molecular interactions.